Literature DB >> 32664802

Emergence of Resistant Clones in Medullary Thyroid Cancer May Not Be Rescued by Subsequent Salvage Highly Selective Rearranged During Transfection-Inhibitor Therapy.

Justine Y Bruce1, Keith C Bible2, Ashish V Chintakuntlawar2.   

Abstract

Entities:  

Year:  2020        PMID： 32664802     DOI： 10.1089/thy.2020.0449

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  2 in total

Review 1.  Predictive Biomarkers in Thyroid Cancer.

Authors:  Elisabetta Macerola; Anello Marcello Poma; Paola Vignali; Agnese Proietti; Clara Ugolini; Liborio Torregrossa; Alessio Basolo; Rossella Elisei; Ferruccio Santini; Fulvio Basolo
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

Review 2.  Precision therapy for RET-altered cancers with RET inhibitors.

Authors:  Kyaw Z Thein; Vamsidhar Velcheti; Blaine H M Mooers; Jie Wu; Vivek Subbiah
Journal:  Trends Cancer       Date:  2021-08-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.